On Oct 26, 2021 Cambrian Biopharma closed a Series C round and raised $100,000,000 from Anthos Capital, Apeiron Investment Group, Future Ventures, Moore Capital, SALT Fund, featuring lead investors Anthos Capital, SALT Fund.

About the company: Cambrian Biopharma is located at United States, North America.
“Cambrian is developing a raft of new companies and therapies to extend healthy lifespan, bringing proven scientific and organizational expertise to exceptional research teams worldwide.”

Company website: http://www.cambrianbio.com